Phase 3 Peripheral Neuropathy Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who weigh at least 45 kilograms
• People whose body mass index (a measure of body weight relative to height) is between 18 and below 40
• People who have been diagnosed with type 1 or type 2 diabetes, have a blood sugar control reading (HbA1c) of 9% or below, and have had pain in both legs or feet due to diabetic nerve damage for at least 1 year
• People whose average daily pain score over a 7-day starting period sits between 4 and 9 out of 10, and remains fairly consistent throughout that period

Who may not be able to join:

• People who missed recording their daily pain score on more than 3 days during the 7-day starting period
• People who have taken the medication Journavx within 30 days before the study medication is due to begin
• People who have nerve-related sensory problems caused by something other than diabetic nerve damage, as outlined in the study rules (confirm with trial site)
• Other criteria set out in the study protocol may also apply (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.